MPG.eBooks - Description: Sofosbuvir (Sovaldi)

Cover Image

Read Now

Sofosbuvir (Sovaldi) sofosbuvir is indicated for the treatment of chronic hepatitis C virus (CHC) infection in adult patients with compensated liver disease, including cirrhosis

To perform a systematic review of the beneficial and harmful effects of sofosbuvir in combination with other agents for the treatment of adults with chronic hepatitis C virus (CHC) infection (genotypes 1, 2, 3, or 4)

Bibliographic Details
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2014, 2014 Oct
Series:	Common drug review
Subjects:	Uridine Monophosphate / Analogs & Derivatives Uridine Monophosphate / Therapeutic Use Treatment Outcome Liver Cirrhosis / Drug Therapy Hepatitis C, Chronic / Drug Therapy
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK253709
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	To perform a systematic review of the beneficial and harmful effects of sofosbuvir in combination with other agents for the treatment of adults with chronic hepatitis C virus (CHC) infection (genotypes 1, 2, 3, or 4)
Item Description:	Title from HTML caption title
Physical Description:	1 online resource illustrations